Gökhan Karataş
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gökhan Karataş has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Osman Kula
Department of Radiology, Faculty of Medicine, Trakya University, Edirne, Turkey
2 shared publications - Atınç Tozsin
Department of Urology, Trakya University School of Medicine, Edirne, Turkey
1 shared publication - Burak Akgul
Department of Urology, Faculty of Medicine, Trakya University, Edirne 22030, Turkey
1 shared publication - Burak Günay
Department of Radiology, Trakya University Faculty of Medicine, Turkey
1 shared publication - Burcu Orug Köseer
Department of Radiology, Trakya University Faculty of Medicine, Edirne, Türkiye
1 shared publication - Ersan Arda
Department of Urology, Faculty of Medicine, Trakya University, Edirne 22030, Turkey
1 shared publication
Latest Publications
- Open Access
- 22 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (21) , 3441
Preprocedural Serum Albumin and Early Contrast-Associated Acute Kidney Injury After Elective Carotid Artery Stenting: Incremental Prognostic Information Beyond the PCI-Derived Mehran Score
Background/Objectives: We assessed whether preprocedural serum albumin adds prognostic information to the PCI-derived Mehran score for early contrast-associated acute kidney injury (CA-AKI) after elective carotid artery stenting (CAS). Methods: This single-centre retrospective cohort included 121 consecutive elective patients (January 2020–April 2026). The primary model combined the reconstructed Mehran score with albumin < 3.5 g/dL, a conventional threshold fixed in advance. Because the score uses actual contrast volume, the combined model applies only after CAS. The outcome used KDIGO serum creatinine thresholds (≥0.3 mg/dL or ≥1.5 times baseline) from routine second-day testing. Internal validation used 1000 bootstrap resamples. Results: Early CA-AKI occurred in 32 patients (26.4%). Adjusted odds ratios were 1.35 per Mehran point (95% CI 1.13–1.60) and 11.68 for albumin < 3.5 g/dL (95% CI 4.14–32.97). AUC increased from 0.768 to 0.865 (95% CI 0.794–0.937; likelihood ratio χ2 = 24.58, p < 0.001). Corrected AUC, calibration slope, and Brier score were 0.860, 0.96, and 0.132. In exploratory decision curves (20% threshold), corrected net benefit was 0.168 for the combined model and 0.133 for Mehran alone. Conclusions: Low preprocedural albumin added prognostic information to the PCI-derived score and may help select patients for closer renal surveillance after CAS. External validation and prospective impact studies are needed before clinical use.
- 22 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (21) , 3441
Open AccessPreprocedural Serum Albumin and Early Contrast-Associated Acute Kidney Injury After Elective Carotid Artery Stenting: Incremental Prognostic Information Beyond the PCI-Derived Mehran Score
Background/Objectives: We assessed whether preprocedural serum albumin adds prognostic information to the PCI-derived Mehran score for early contrast-associated acute kidney injury (CA-AKI) after elective carotid artery stenting (CAS). Methods: This single-centre retrospective cohort included 121 consecutive elective patients (January 2020–April 2026). The primary model combined the reconstructed Mehran score with albumin < 3.5 g/dL, a conventional threshold fixed in advance. Because the score uses actual contrast volume, the combined model applies only after CAS. The outcome used KDIGO serum creatinine thresholds (≥0.3 mg/dL or ≥1.5 times baseline) from routine second-day testing. Internal validation used 1000 bootstrap resamples. Results: Early CA-AKI occurred in 32 patients (26.4%). Adjusted odds ratios were 1.35 per Mehran point (95% CI 1.13–1.60) and 11.68 for albumin < 3.5 g/dL (95% CI 4.14–32.97). AUC increased from 0.768 to 0.865 (95% CI 0.794–0.937; likelihood ratio χ2 = 24.58, p < 0.001). Corrected AUC, calibration slope, and Brier score were 0.860, 0.96, and 0.132. In exploratory decision curves (20% threshold), corrected net benefit was 0.168 for the combined model and 0.133 for Mehran alone. Conclusions: Low preprocedural albumin added prognostic information to the PCI-derived score and may help select patients for closer renal surveillance after CAS. External validation and prospective impact studies are needed before clinical use.
- Open Access
- 20 July 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (14) , 1574
Comparison of the Efficacy of Percutaneous Microwave Ablation Therapy versus Laparoscopic Partial Nephrectomy for Early-Stage Renal Tumors
This study aimed to compare the efficacy of percutaneous microwave ablation therapy (MWAT) and laparoscopic partial nephrectomy (LPN) in early-stage renal cell carcinoma (RCC) classified as T1a; a retrospective analysis was conducted on patients treated between January 2017 and November 2023. Oncological outcomes, radiological recurrence, length of stay (LOS), and costs were evaluated. The study included 110 patients, with no significant differences between the two groups regarding residual tumors, local tumor progression, and disease-free survival rates (p > 0.05). The LPN group showed significantly lower pre/postoperative serum urea and creatinine and higher estimated glomerular filtration rate values, whereas the MWA group experienced significantly lower mean costs, complication rates, LOS in the hospital, and procedure durations (p ≤ 0.05). However, post-procedure residual tumors and local tumor progression rates did not differ significantly between the LPN and MWAT groups (p > 0.05). MWAT is as effective as LPN for T1a RCC lesions. In addition, MWAT has lower costs than LPN and is a cost-effective treatment method. Therefore, MWAT minimizes hospital stay and complications and since the oncological results are similar to LPN, it might be considered as the first choice of treatment in young patients.
- 20 July 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (14) , 1574
Open AccessComparison of the Efficacy of Percutaneous Microwave Ablation Therapy versus Laparoscopic Partial Nephrectomy for Early-Stage Renal Tumors
This study aimed to compare the efficacy of percutaneous microwave ablation therapy (MWAT) and laparoscopic partial nephrectomy (LPN) in early-stage renal cell carcinoma (RCC) classified as T1a; a retrospective analysis was conducted on patients treated between January 2017 and November 2023. Oncological outcomes, radiological recurrence, length of stay (LOS), and costs were evaluated. The study included 110 patients, with no significant differences between the two groups regarding residual tumors, local tumor progression, and disease-free survival rates (p > 0.05). The LPN group showed significantly lower pre/postoperative serum urea and creatinine and higher estimated glomerular filtration rate values, whereas the MWA group experienced significantly lower mean costs, complication rates, LOS in the hospital, and procedure durations (p ≤ 0.05). However, post-procedure residual tumors and local tumor progression rates did not differ significantly between the LPN and MWAT groups (p > 0.05). MWAT is as effective as LPN for T1a RCC lesions. In addition, MWAT has lower costs than LPN and is a cost-effective treatment method. Therefore, MWAT minimizes hospital stay and complications and since the oncological results are similar to LPN, it might be considered as the first choice of treatment in young patients.
- Open Access
- 3 May 2024
- Published by The European Research Journal in The European Research Journal
- Vol. 10 (3) , 268-275
Relationship of breast arterial calcification and radiotherapy
Objective: The purpose of this research is to compare the pre and post-radiotherapy mammograms of patients who had breast-conserving surgery (BCS) and radiotherapy to see how radiotherapy affects breast arterial calcifications (BAC). Methods: The study retrospectively compared the mammography examinations at least 24 months after radiotherapy and pre-radiotherapy mammography examinations of 123 female patients diagnosed with breast cancer and treated with BCS and radiotherapy between December 2001 and July 2011. Results: Breast arterial calcifications (BAC) increased statistically significantly in 25 patients who underwent radiotherapy after BCS. Conclusion: Our results indicate that BAC increases significantly after RT, especially in breasts treated with radiotherapy, with age being also a risk factor for BAC development.
- 3 May 2024
- Published by The European Research Journal in The European Research Journal
- Vol. 10 (3) , 268-275
Open AccessRelationship of breast arterial calcification and radiotherapy
Objective: The purpose of this research is to compare the pre and post-radiotherapy mammograms of patients who had breast-conserving surgery (BCS) and radiotherapy to see how radiotherapy affects breast arterial calcifications (BAC). Methods: The study retrospectively compared the mammography examinations at least 24 months after radiotherapy and pre-radiotherapy mammography examinations of 123 female patients diagnosed with breast cancer and treated with BCS and radiotherapy between December 2001 and July 2011. Results: Breast arterial calcifications (BAC) increased statistically significantly in 25 patients who underwent radiotherapy after BCS. Conclusion: Our results indicate that BAC increases significantly after RT, especially in breasts treated with radiotherapy, with age being also a risk factor for BAC development.